Outcome Predictors in COVID-19: An Analysis of Emergent Systemic Inflammation Indices in Mexican Population

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Nov 7

PMID 36341268

Authors

Ilse Adriana Gutierrez-Perez

Ivette Buendia-Roldan

Gloria Perez-Rubio

Leslie Chavez-Galan

Rafael De Jesus Hernandez-Zenteno

Hiram Aguilar-Duran

Ingrid Fricke-Galindo

Oscar Zaragoza-Garcia

Ramces Falfan-Valencia

Iris Paola Guzman-Guzman

Affiliations

Soon will be listed here.

Abstract

Introduction: The systemic viral disease caused by the SARS-CoV-2 called coronavirus disease 2019 (COVID-19) continues to be a public health problem worldwide.

Objective: This study is aimed to evaluate the association and predictive value of indices of systemic inflammation with severity and non-survival of COVID-19 in Mexican patients.

Materials And Methods: A retrospective study was carried out on 807 subjects with a confirmed diagnosis of COVID-19. Clinical characteristics, acute respiratory distress syndrome (ARDS), severity according to PaO/FiO ratio, invasive mechanical ventilation (IMV), and non-survival outcome were considered to assess the predictive value and the association of 11 systemic inflammatory indices derived from hematological parameters analyzed at the hospital admission of patients. The receiver operating characteristics curve was applied to determine the thresholds for 11 biomarkers, and their prognostic values were assessed the Kaplan-Meier method.

Results: 26% of the studied subjects showed COVID-19 severe (PaO/FiO ratio ≤ 100), 82.4% required IMV, and 39.2% were non-survival. The indices NHL, NLR, RDW, dNLR, and SIRI displayed predictive values for severe COVID-19 and non-survival. NHL, SIRI, and NLR showed predictive value for IMV. The cut-off values for RDW (OR = 1.85, < 0.001), NHL (OR = 1.67, = 0.004) and NLR (OR = 1.56, = 0.012) were mainly associated with severe COVID-19. NHL (OR = 3.07, < 0.001), AISI (OR = 2.64, < 0.001) and SIRI (OR = 2.51, < 0.001) were associated with IMV support, while for non-survival the main indices associated were NHL (OR = 2.65, < 0.001), NLR (OR = 2.26, < 0.001), dNLR (OR = 1.92, < 0.001), SIRI (OR = 1.67, = 0.002) and SII (OR = 1.50, = 0.010). The patients with an RDW, PLR, NLR, dNLR, MLR, SII, and NHL above the cut-off had a survival probability of COVID-19 50% lower, with an estimated mean survival time of 40 days.

Conclusion: The emergent systemic inflammation indices NHL, NLR, RDW, SII, and SIRI have a predictive power of severe COVID-19, IMV support, and low survival probability during hospitalization by COVID-19 in Mexican patients.

Citing Articles

Immunoinflammatory markers SIRI and NAR as predictors of respiratory distress syndrome and secondary infections in premature infants.

Chen X, Li Y, Chen H, Chen W Front Cell Infect Microbiol. 2024; 14:1512884.

PMID: 39735264 PMC: 11673761. DOI: 10.3389/fcimb.2024.1512884.

Correlations between frailty index and inflammatory markers derived from blood cell count in the United States.

Han S, Zhang Z, Cheng S, Han Y, Wang Q, Xi Y BMC Public Health. 2024; 24(1):3408.

PMID: 39695452 PMC: 11653688. DOI: 10.1186/s12889-024-20908-9.

Differential Inflammatory and Immune Response to Viral Infection in the Upper-Airway and Peripheral Blood of Mild COVID-19 Cases.

Gajate-Arenas M, Garcia-Perez O, Dominguez-de-Barros A, Sirvent-Blanco C, Dorta-Guerra R, Garcia-Ramos A J Pers Med. 2024; 14(11).

PMID: 39590591 PMC: 11595938. DOI: 10.3390/jpm14111099.

Use of machine learning to identify protective factors for death from COVID-19 in the ICU: a retrospective study.

Dos Santos L, Silva L, Pelloso F, Maia V, Pujals C, Borghesan D PeerJ. 2024; 12:e17428.

PMID: 38881861 PMC: 11179634. DOI: 10.7717/peerj.17428.

The Immune Response of , , and Genes in the Pathogenesis of COVID-19.

Gajate-Arenas M, Fricke-Galindo I, Garcia-Perez O, Dominguez-de-Barros A, Perez-Rubio G, Dorta-Guerra R Int J Mol Sci. 2024; 25(9).

PMID: 38731851 PMC: 11083791. DOI: 10.3390/ijms25094632.

References

Maguire D, Woods M, Richards C, Dolan R, Wilson Veitch J, Sim W . Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. J Transl Med. 2020; 18(1):354. PMC: 7491021. DOI: 10.1186/s12967-020-02524-4. View

Zirpe K, Tiwari A, Gurav S, Deshmukh A, Suryawanshi P, Wankhede P . Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Indian J Crit Care Med. 2021; 25(5):493-498. PMC: 8196392. DOI: 10.5005/jp-journals-10071-23816. View

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-768. PMC: 7108125. DOI: 10.1093/cid/ciaa248. View

Tomar B, Anders H, Desai J, Mulay S . Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19. Cells. 2020; 9(6). PMC: 7348784. DOI: 10.3390/cells9061383. View

Choe J, Kim S . Association between Hematological Indicesand Disease Activity in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors for 24 Weeks. Medicina (Kaunas). 2022; 58(3). PMC: 8952825. DOI: 10.3390/medicina58030426. View

Veras F, Cornejo Pontelli M, Silva C, Toller-Kawahisa J, de Lima M, Nascimento D . SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020; 217(12). PMC: 7488868. DOI: 10.1084/jem.20201129. View

Ioannou G, Locke E, Green P, Berry K, OHare A, Shah J . Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. JAMA Netw Open. 2020; 3(9):e2022310. PMC: 7512055. DOI: 10.1001/jamanetworkopen.2020.22310. View

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C . Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020; 18(1):206. PMC: 7237880. DOI: 10.1186/s12967-020-02374-0. View

Erdogan A, Can F, Gonullu H . Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients. J Med Virol. 2021; 93(9):5555-5559. PMC: 8242916. DOI: 10.1002/jmv.27097. View

10.

Fois A, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R . The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020; 25(23). PMC: 7731255. DOI: 10.3390/molecules25235725. View

11.

Fouad S, Allam M, Taha S, Okba A, Hosny A, Moneer M . Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19. J Int Med Res. 2021; 49(7):3000605211030124. PMC: 8278465. DOI: 10.1177/03000605211030124. View

12.

Yang A, Liu J, Tao W, Li H . The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020; 84:106504. PMC: 7152924. DOI: 10.1016/j.intimp.2020.106504. View

13.

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

14.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

15.

Hamad D, Aly M, Abdelhameid M, Abdalla Ahmed S, Shaltout A, Abdel-Moniem A . Combined Blood Indexes of Systemic Inflammation as a Mirror to Admission to Intensive Care Unit in COVID-19 Patients: A Multicentric Study. J Epidemiol Glob Health. 2021; 12(1):64-73. PMC: 8668150. DOI: 10.1007/s44197-021-00021-5. View

16.

Thammavongsa V, Missiakas D, Schneewind O . Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science. 2013; 342(6160):863-6. PMC: 4026193. DOI: 10.1126/science.1242255. View

17.

Soehnlein O, Steffens S, Hidalgo A, Weber C . Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017; 17(4):248-261. DOI: 10.1038/nri.2017.10. View

18.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

19.

Bastug A, Bodur H, Erdogan S, Gokcinar D, Kazancioglu S, Kosovali B . Clinical and laboratory features of COVID-19: Predictors of severe prognosis. Int Immunopharmacol. 2020; 88:106950. PMC: 7480980. DOI: 10.1016/j.intimp.2020.106950. View

20.

Rodriguez-Morales A, Cardona-Ospina J, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana J . Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 34:101623. PMC: 7102608. DOI: 10.1016/j.tmaid.2020.101623. View